Cite
MLA Citation
Robert I. Haddad et al.. “Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651.” Journal of clinical oncology, vol. 41, no. 12, 2023, pp. 2166–2180. http://access.bl.uk/ark:/81055/vdc_100184341263.0x000016